BS
Brett Sandercock
Chief Financial Officer

Brett Sandercock insider trades: Resmed (RMD) stock sales

Chief Financial Officer, Resmed Last trade Apr 1, 2026 167 Form 4 filings
$1.2M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
133
Open-market trades
since 2006
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brett reports to the SEC

Open-market buys and sales

133 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2026RMD↓ Sell$224K
Mar 2, 2026RMD↓ Sell$254K
Feb 2, 2026RMD↓ Sell$257K
Jan 2, 2026RMD↓ Sell$242K
Dec 1, 2025RMD↓ Sell$244K
Nov 3, 2025RMD↓ Sell$743K
Oct 1, 2025RMD↓ Sell$823K
Sep 2, 2025RMD↓ Sell$812K
Aug 1, 2025RMD↓ Sell$846K
Jul 1, 2025RMD↓ Sell$998K
Jun 2, 2025RMD↓ Sell$244K
May 22, 2025RMD↓ Sell$891K
Apr 8, 2025RMD↓ Sell$216K
Mar 10, 2025RMD↓ Sell$230K
Feb 10, 2025RMD↓ Sell$239K
Jan 8, 2025RMD↓ Sell$234K
Dec 9, 2024RMD↓ Sell$244K
Nov 8, 2024RMD↓ Sell$249K
Oct 8, 2024RMD↓ Sell$233K
Sep 9, 2024RMD↓ Sell$246K
Aug 8, 2024RMD↓ Sell$212K
Jul 8, 2024RMD↓ Sell$194K
Jun 10, 2024RMD↓ Sell$210K
May 8, 2024RMD↓ Sell$2.7M
Nov 27, 2023RMD↓ Sell$458K
May 10, 2023RMD↓ Sell$2.9M
May 9, 2023RMD↓ Sell$795K
Feb 17, 2023RMD↓ Sell$2.2M
Feb 13, 2023RMD↓ Sell$860K
Nov 7, 2022RMD↓ Sell$848K
Aug 10, 2022RMD↓ Sell$602K
Jul 22, 2022RMD↓ Sell$1.8M
Apr 11, 2022RMD↓ Sell$618K
Mar 10, 2022RMD↓ Sell$603K
Feb 10, 2022RMD↓ Sell$605K
Jan 10, 2022RMD↓ Sell$588K
Dec 10, 2021RMD↓ Sell$662K
Nov 10, 2021RMD↓ Sell$651K
Oct 11, 2021RMD↓ Sell$1.3M
Sep 10, 2021RMD↓ Sell$1.5M
Aug 20, 2021RMD↓ Sell$3.0M
Aug 10, 2021RMD↓ Sell$695K
Jul 12, 2021RMD↓ Sell$621K
Jun 10, 2021RMD↓ Sell$532K
May 10, 2021RMD↓ Sell$490K
Apr 12, 2021RMD↓ Sell$496K
Mar 10, 2021RMD↓ Sell$463K
Feb 10, 2021RMD↓ Sell$503K
Jan 11, 2021RMD↓ Sell$547K
Dec 10, 2020RMD↓ Sell$528K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RMD insiders

Open-market trades in the last 12 months

About Brett Sandercock's insider trades

Brett Sandercock is Chief Financial Officer at Resmed (RMD). Since Jun 1, 2006, Brett has reported no open-market purchases and 133 sales worth $74.5M on SEC Form 4. In the last 12 months: 5 sales ($1.2M).

5 sales (4% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (36 filings), grants and awards (34 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.